iifl-logo

Sun Pharmaceuticals Industries Ltd Board Meeting

1,593.6
(0.71%)
Sep 5, 2025|12:00:00 AM

Sun Pharma.Inds. CORPORATE ACTIONS

06/09/2024calendar-icon
06/09/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting31 Jul 202511 Jul 2025
Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve Unaudited Financial Results for the Q1 of FY 2025-26 Outcome of Board Meeting Financial results for the quarter ended 30 June 2025 (As Per BSE Announcement Dated on :31.07.2025)
Board Meeting22 May 202512 May 2025
Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 inter alia to consider and approve Board Meeting Intimation for approval of audited financial results and Final Dividend if any Board recommended final dividend Appointment of Secretarial Auditor Outcome of Board Meeting (As Per BSE Announcement Dated on 22.05.2025)
Board Meeting31 Jan 202516 Jan 2025
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve financial results for the quarter and nine months ended December 31 2024 and interim dividend Intimation regarding record date for the purpose of interim dividend, if declared Board approved interim dividend for FY 2024-25 (As Per BSE Announcement Dated on 30/01/2025)
Board Meeting28 Oct 20249 Oct 2024
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve Financial Results for the quarter and half year ended September 30 2024 Financial results for quarter and half year ended September 30, 2024 (As Per BSE Announcement dated on 28.10.2024)

Sun Pharma.Inds.: Related News

Top Stocks for Today - 15th July 2025

Here are some of the stocks that may see significant price movement today: Power Mech Projects, Rail Vikas Nigam, Rallis India, etc.

15 Jul 2025|06:24 AM
Read More
Top Stocks for Today - 16th June 2025

Here are some of the stocks that may see significant price movement today: Sun Pharma, Vedanta, SpiceJet, etc.

16 Jun 2025|06:23 AM
Read More
US FDA Flags 8 Observations at Sun Pharma’s Halol Facility After GMP Inspection

The visit lasted from June 2 to June 13 and focused on checking for compliance with Good Manufacturing Practices.

15 Jun 2025|11:50 PM
Read More
Sun Pharma Expands Specialty Drug Pipeline with $25 Million Pharmazz Deal

Both treatments have already received approvals in India and are available for sale there with local partners under a brand known as Tyvalzi and Lyfaquin.

24 May 2025|07:51 PM
Read More
Sun Pharma Q4 FY25 Revenue Rises 8.5% to ₹12,816 Crore

The Board recommended a final dividend of ₹5.50 per share for FY25.

23 May 2025|12:07 PM
Read More
Top Stocks for Today - 7th May 2025

NLC's subsidiary has executed a PPA with Rajasthan Rajya Vidyut Utpadan Nigam Ltd. (RVUNL) for 810 MW solar power plant at Pugal Solar Park, Rajasthan

7 May 2025|08:06 AM
Read More
Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

26 Apr 2025|01:15 PM
Read More
Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

10 Mar 2025|10:46 AM
Read More
Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

31 Jan 2025|10:17 PM
Read More
Sun Pharma reports Q2 net profit at ₹3,040 Crore

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

29 Oct 2024|10:30 AM
Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.